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Editor\'s key points•The novel coronavirus disease 2019 (COVID-19) is associated with human-to-human transmission.•Exposure to COVID-19 may result in acute respiratory failure for healthcare workers.•The risk of emergent surgery, including Caesarean section, where spinal anaesthesia is the optimal choice for both patients and healthcare providers, is unclear.•Spinal anaesthesia was delivered safely in patients (mostly women requiring Caesarean sections) with active, although mild, COVID-19 infection.•Level 3 personal protective equipment appears to reduce the risk of transmission to anaesthetists who are exposed to mildly symptomatic surgical patients.

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), termed coronavirus disease 2019 (COVID-19), in Wuhan, Hubei Province, China since early December 2019[@bib1] ^,^ [@bib2] has brought the healthcare system to a standstill. As of March 3, 2020, 80 303 confirmed cases have been documented in China. The highly infectious features of SARS-CoV-2 have resulted in a public health emergency of international concern, as declared by the WHO.

Several reports have now described the epidemiological, clinical, laboratory, and radiological characteristics of patients with confirmed COVID-19, including pregnant women who undergo Caesarean section. However, the perioperative characteristics and anaesthetic management of surgical patients with confirmed COVID-19, including those undergoing Caesarean section, have not been reported, although clinical recommendations have recently been published.[@bib3]

As person-to-person transmission of COVID-19 occurs in hospitals,[@bib4], [@bib5], [@bib6] surgical procedures, in which neuraxial techniques are usually deemed to provide optimal anaesthesia, may place clinicians at particularly high risk when caring for infected patients. The objective of this report was to share our experience of performing spinal anaesthesia in patients with COVID-19, by reporting the perioperative characteristics and outcome of surgical patients in whom spinal anaesthesia was undertaken. In addition, we report the possible impact of spinal anaesthesia on anaesthetists after exposure to COVID-19.

Methods {#sec1}
=======

Study design {#sec1.1}
------------

This was a single-centre, retrospective study conducted at Zhongnan Hospital of Wuhan University between January 1, 2020 and February 14, 2020. The study was approved by the Institutional Ethics Board of Zhongnan Hospital of Wuhan University (reference: 2020049). Verbal consent was obtained from patients and anaesthetists.

Participants {#sec1.2}
------------

Patients undergoing spinal anaesthesia were enrolled if they had clinically confirmed COVID-19, in accord with current diagnostic criteria.[@bib7] We also identified the anaesthesiologists who delivered clinical care to patients confirmed as having COVID-19 during surgery, but who had no contact with confirmed COVID-19 patients beyond the operating theatre.

### Confirmation of COVID-19 diagnosis {#sec1.2.1}

Throat swab samples obtained from patients and anaesthetists were tested for SARS-CoV-2 with the Chinese Center for Disease Control and Prevention recommended reverse transcription--polymerase chain reaction (RT--PCR) test (BioGerm, Shanghai, China). Coronavirus disease 2019 infection was confirmed by a positive RT--PCR test result undertaken in the clinical laboratory of Zhongnan Hospital.

### Data collection: surgical patients {#sec1.2.2}

We extracted data detailing sex, age, operation type, clinical characteristics (including symptoms/signs, blood test results, chest CT scans, and throat swab nucleic acid), and type of surgery from electronic medical records. Heart rate, oxygen saturation, and noninvasive blood pressure at the start of anaesthesia and after 5 min of the end of anaesthesia for all patients were compared. Leucocyte counts before and 3 days after surgery were also recorded.

### Data collection: anaesthetists {#sec1.2.3}

We analysed data from anaesthetists who had directly cared (within 1 m proximity) for patients with confirmed COVID-19, but who had no contact with patients with COVID-19 outside the hospital. We recorded sex, age, and clinical characteristics (including the development of symptoms/signs, blood test results, chest CT scans, and throat swab testing for COVID-19). We also recorded the personal protective equipment (PPE) worn by each anaesthetist undertaking spinal anaesthesia, as defined by the EU Regulation 2016/425. Category 3 PPE is required when the highest level of respiratory, skin, eye, and mucous membrane protection is needed, including positive pressure (pressure demand), self-contained breathing apparatus, and a fully encapsulating chemical protective suit plus inner and outer chemical resistant gloves. Category 1 PPE is limited to surgical mask, hat, gloves, and gowns.

Statistical analysis {#sec1.3}
--------------------

Two study investigators (JJZ and HXJ) independently reviewed all data to verify accuracy. Descriptive data are presented as mean (standard deviation) (or median \[inter-quartile range\]) for continuous variables, and *n* (%) for categorical variables. We used Wilcoxon\'s signed-rank test for paired non-parametric comparisons. We assessed different frequency rates between different levels of PPE using the χ^2^ test. Statistical analysis was performed using the SPSS 21.0 statistical software (SPSS, Inc. Chicago, IL, USA).

Results {#sec2}
=======

Patient characteristics {#sec2.1}
-----------------------

We identified 49 patients with radiologically confirmed COVID-19. The patient characteristics and symptoms are summarised in [Table 1](#tbl1){ref-type="table"} . Fever was the most common symptom. Positive confirmation of COVID-19 by RT--PCR was recorded in 13/49 (26.5%) patients. Every patient required supplemental oxygen (delivered by nasal cannula) before surgery.Table 1Characteristics of surgical patients with COVID-19 infection. Data are presented as median (IQR) or *n* (%). ASA, American Society of Anesthesiologists; COVID-19, coronavirus disease 2019; IQR, inter-quartile range; RT--PCR, reverse transcription--polymerase chain reaction.Table 1CharacteristicsNAge, Median (IQR), y31 (29--34）Female sex42 (85.7%)BMI, Median (IQR), kg/m^2^35.2 (33.25--36.4)Duration from onset of symptoms to radiological confirmation of pneumonia, Median (IQR), days3 (5--8)Duration from onset of symptoms to operation room, Median (IQR), days2 (0.5--3)Symptom Cough21 (42.8%) Sore throat14 (28.6%) Myalgia6 (12.2%) Shortness of breath4 (8.2%) Gastrointestinal reaction2 (4.0%)Fever(°C) \<37.323 (46.9%) 37.3--37.921 (42.9%) 38.0--38.93 (6.1%) \>=392 (4.1%)Positive RT-PCR for COVID-1913 (26.5%)Comorbidities Hypertension4 (8.2%) Diabetes mellitus2 (4.1%) Thyroid dysfunction2 (4.1%)Operation type Caesarean section45 (91.8%) Orthopedic4 (8.2%)ASA physical status 143 (87.8%) 26 (12.2%)Treatment Nasal cannula49 (100%) Antiviral agents29 (59.2%) Antibacterial agents47 (95.9%)Progress to severe Pneumonia Yes0 (0%) No100 (100%)Complication Vomit3 (6.1%)

Spinal anaesthesia {#sec2.2}
------------------

Spinal anaesthesia was performed in the lateral decubitus position at the level of L3--L4. After local skin infiltration with lidocaine 2% (2 ml), isobaric ropivacaine 0.75% (2.2 ml) was injected intrathecally using 25-gauge needles. Spinal anaesthesia was well tolerated, with heart rate, blood pressure, and oxygen saturation remaining stable after surgery. Prophylactic anti-emetics were administered to decrease the risk of vomiting and viral spread.

Postoperative outcomes {#sec2.3}
----------------------

Three (6.1%) of 49 patients vomited after spinal anaesthesia was established. After surgery, the total leucocyte count and neutrophil counts were higher, accompanied by a lower lymphocyte count ([Table 2](#tbl2){ref-type="table"} ). No surgical patients developed severe pneumonia or died of COVID-19 pneumonia after surgery, as of February 14, 2020 ([Table 1](#tbl1){ref-type="table"}).Table 2Perioperative characteristics of surgical patients with coronavirus disease 2019 infection. ∗Laboratory values obtained 3 days after surgery.Table 2VariableBefore surgeryAfter surgery*P*-valueTotal leucocytes (10^9^ L^−1^)8.0 (6.5--10.5)9.2 (6.3--11.3)∗0.01Neutrophil count (10^9^ L^−1^)6.3 (4.6--9.1)7.4 (5.1--9.5)∗0.01Lymphocyte count (10^9^ L^−1^)1.38 (0.96--1.72)1.33 (0.77--1.6)∗\<0.01Systolic blood pressure (mm Hg)128 (120--144)124 (116--134)0.12Diastolic blood pressure (mm Hg)80 (73--85)78 (70--88)0.75Heart rate (beats min^−1^)84 (84--95)84 (84--94)0.55Oxygen saturation (%)100 (99--100)100 (99--100)0.45

Anaesthetists {#sec2.4}
-------------

Forty-four anaesthetists (30 females; 68.2%) had direct contact with patients with COVID-19. Of these 44 anaesthetists, 26 (59%) were taking umifenovir, a broad-spectrum antiviral compound that blocks membrane fusion between the virus and target host cells. The majority of the staff wore Level 3 PPE in the operating theatre ([Table 3](#tbl3){ref-type="table"} ). Coronavirus disease 2019 infection was subsequently confirmed by PCR in five/44 (11.4%) anaesthetists. Of 37 anaesthetists who wore Category 3 PPE, one (2.7%) developed PCR-confirmed COVID-19 compared with four/seven (57.1%) anaesthetists who had Category 1 protection in the operating theatre (relative risk reduction: 95.3% \[95% confidence intervals: 63.7--99.4\]; *P*\<0.01) ([Table 4](#tbl4){ref-type="table"} ). Of the five anaesthetists who were infected ([Table 5](#tbl5){ref-type="table"}), none had family members with COVID-19. Although the symptoms were mild, two required hospital treatment for supplementary oxygen despite mostly normal pulmonary CT scans ([Fig. 1](#fig1){ref-type="fig"} ). The other three anaesthetists were quarantined at home. All five anaesthetists were treated with antiviral and antibacterial agents ([Table 5](#tbl5){ref-type="table"} ).Table 3Characteristics of 44 anaesthetists who cared for patients with coronavirus disease 2019 infection. Data are presented as median (inter-quartile range) or *n* (%).Table 3CharacteristicAge (yr)33 (28--35)Female gender30 (68.2)BMI (kg m^−2^)23.1 (21.9--24.8)Level 3 personal protective equipment37 (84.1)Operative time (h)3.8 (2--5)Table 4Symptoms of anaesthetists at time of delivering spinal anaesthesia. Data are presented as *n* (%). PCR, polymerase chain reaction; PPE, personal protective equipment.Table 4CharacteristicTotal (*n*=44)Level 3 PPE (*n*=37)Level 1 PPE (*n*=7)*P*-valueFemale sex30 (68.2)25 (67.6)5 (71.4)0.61SymptomsFever1 (2.3)1 (2.7)0 (0)0.84Fatigue8 (18.2)6 (16.2)2 (28.6)0.38Cough19 (35)18 (48.6)1 (14.3)0.10Myalgia7 (15.9)6 (16.2)1 (14.3)0.69Sore throat10 (22.7)9 (24.3)1 (14.3)0.49Diarrhoea4 (9.1)3 (8.1)1 (14.3)0.51Headache11 (25)9 (24.3)2 (28.6)0.57Umifenovir therapy26 (59.1)23 (62.2)3 (42.9)0.29PCR confirmed5 (11.4)1 (2.7)4 (57.1)\<0.01CT confirmed1 (2.3)0 (0)1 (14.3)0.16Fig 1Chest CT scans (transverse plane) of five anaesthetists infected with coronavirus disease 2019 (COVID-19). (a) Anaesthetist 1: multiple bilateral ground-glass opacities, most prominent on the right. (b--e) Anaesthetists 2--5: no changes on CT scan despite confirmation of COVID-19 via reverse transcription--polymerase chain reaction tests on throat swab sample.Fig 1Table 5Clinical characteristics of anaesthetists who acquired COVID-19 after delivering spinal anaesthesia. ∗Quarantined at home. ^†^Each individual infected anaesthetist. COVID-19, coronavirus disease 2019; RT--PCR, reverse transcription--polymerase chain reaction.Table 51^†^2^†^3^†^4^†^5^†^CharacteristicsAge (yr)4840303428GenderFemaleFemaleFemaleMaleFemaleFamily members affectedNoNoNoNoNoCoexisting conditionsNoNoNoNoNoSymptoms FeverNoNoNoNoNo FatigueYesNoNoNoNo MyalgiaYesNoNoNoNo MalaiseNoNoNoNoNo CoughNoNoNoNoNo Sore throatNoNoNoNoNo Chest painNoNoNoNoNo DiarrhoeaNoNoNoNoNoCOVID-19 diagnostic testsRT--PCRPositivePositivePositivePositivePositiveCT scanPositiveNegativeNegativeNegativeNegativeTreatmentLocationHospitalHospitalHome∗Home∗Home∗AntiviralsYesYesYesYesYesAntibioticsYesYesYesYesYesSupplementary oxygenYesYesNoNoNo

Discussion {#sec3}
==========

This is the largest case series exploring the risk for anaesthetists of developing COVID-19 through exposure to infected surgical patients undergoing spinal anaesthesia. The clinical characteristics of the 49 infected surgical patients were typical of the majority of adults with COVID-19 infection.[@bib8] We found that spinal anaesthesia had no adverse effects, either during the intraoperative period or subsequently. However, based on our follow-up of 44 anaesthetists who delivered spinal anaesthesia, our data suggest that Level 3 PPE is likely to reduce the risk of acquiring COVID-19.

Spinal anaesthesia is the anaesthetic of choice for many surgical procedures, in particular Caesarean sections.[@bib9] However, whether the risk of spinal anaesthesia to anaesthetists being undertaken in patients with COVID-19 is uncertain. Using ropivacaine, we found that spinal anaesthesia had no adverse impact during the intraoperative period.[@bib10] Typical changes in leucocyte count were observed after surgery.[@bib11] Most importantly, spinal anaesthesia did not appear to worsen the outcome of patients with SARS-CoV-2 pneumonia.

Level 3 PPE[@bib12] was used by most anaesthetists, but seven anaesthetists used Level 1 protection because of delayed confirmation of COVID-19 in patients undergoing surgery. Our study provides further evidence of human-to-human transmission in hospitals, although this is lower than previous reports.[@bib13] Most infected anaesthetists had mild symptoms. The low transmission rate may, however, be attributable to additional factors. First, most operating theatres are under positive pressure with up to 20 room air exchanges per hour, thereby reducing viral exposure rapidly.[@bib14] Second, all surgical patients in this study had mild symptoms. Third, several anaesthetists were fully protected and took prophylactic drugs.

We confirmed previous studies demonstrating that asymptomatic infected anaesthetists, as confirmed by PCR, frequently do not have concomitant radiological abnormalities.[@bib15] False-negative PCR testing for throat swabs has been documented during this outbreak, highlighting the importance of clinical symptoms (fever, fatigue, dry cough, myalgia, and dyspnoea) in recognising COVID-19 at an early stage.[@bib16]

This study clearly has multiple limitations. First, throat swabs were used to diagnose COVID-19 through RT--PCR, rather than blood samples. False-negative tests may occur using throat swab samples. Second, as most patients with COVID-19 undergoing surgery had mild symptoms, we cannot address whether tracheal intubation/extubation is similarly, or more, hazardous compared with regional anaesthesia. We also cannot exclude that anaesthetists became infected through other sources (e.g. colleagues in the hospital).

In summary, spinal anaesthesia appears to be safe in mildly symptomatic COVID-19 patients. Our study suggests that using Level 3 PPE is likely to reduce the risk to anaesthetic staff of acquiring COVID-19 even from patients with mild symptoms. Considering the significance of this ongoing global public health emergency, our report contributes valuable data to inform the perioperative community.
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